Welcome to May SBMer'sHere is what is on Howards to do list for the month of May:
• Finalize due diligence and agree on terms with new organization
• Complete an additional licensing agreement for the SGLT2 inhibitor in new markets
• Secure non-dilutive funding through anticipated collaborations
• Finalize Tinyi agreement
• Complete Phase I clinical trial in China for the SGLT2 Inhibitor and advance to Phase II
• Complete safety studies and enter clinical trial for anti-wrinkle compound
• Develop new anti-viral compounds and advance them into preclinical studies
I don't think he'll have to time to work at the hospital much this month. Just get the animal diabetes contract signed with the 2 nationals and I'll be happy.